|
|
40
|
|
|
A231D
|
|
|
NEURONTIN 300MG CAP (PFI/SBI) GABAPENTIN
|
|
|
GABAPENTIN
|
|
|
NEURONTIN
|
|
|
100'S
|
|
|
C
|
|
|
150.08
|
|
|
1.50
|
|
|
300MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
SBI
|
|
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
Yes
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|